Business Context and Reporting Period
This Form 8-K filing by iBio, Inc. (Delaware) reports on a Special Meeting of Stockholders held on April 23, 2018. The filing details the voting results regarding corporate governance matters, specifically a proposed reverse stock split and an adjournment proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the outcome of a shareholder vote and does not contain financial performance data.
Material Changes and Voting Results
Shareholders voted on two primary proposals. The total number of shares entitled to vote was 115,918,510, with 63,606,416 shares present in person or by proxy.
- Proposal 1 (Reverse Stock Split): Approved. Shareholders authorized an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1:2 and 1:10.
- For: 60,770,293 shares
- Against: 2,803,522 shares
- Abstentions: 31,381 shares
- Proposal 2 (Adjournment): Approved. Shareholders authorized the adjournment of the meeting to solicit additional proxies if necessary to pass the reverse split proposal.
- For: 60,601,274 shares
- Against: 2,868,910 shares
- Abstentions: 135,012 shares
Guidance, Outlook, and Management Commentary
Following the approval of Proposal 1, the Board of Directors retains the authority to implement the reverse stock split at any time prior to April 23, 2019. The Board will determine the precise ratio within the approved 1:2 to 1:10 range. The split will become effective upon the filing of the Reverse Split Amendment. No specific financial guidance or risk factors were detailed in this specific filing text.
Investor Verification Checklist
- Verify the specific reverse stock split ratio selected by the Board of Directors, as it was not fixed in this filing.
- Monitor future filings for the effective date of the Reverse Split Amendment.
- Review the Proxy Statement on Schedule 14A (filed April 3, 2018) for detailed rationale and risks associated with the reverse split.
- Confirm the impact of the split on the number of outstanding shares and share price once implemented.